| Entity Name: | IMPEL PHARMACEUTICALS INC. |
| Jurisdiction: | FLORIDA |
| Filing Type: | Foreign Profit |
| Status: | Inactive |
| Date Filed: | 29 Jul 2021 (4 years ago) |
| Date of dissolution: | 27 Sep 2024 (4 months ago) |
| Last Event: | REVOKED FOR ANNUAL REPORT |
| Event Date Filed: | 27 Sep 2024 (4 months ago) |
| Document Number: | F21000004291 |
| FEI/EIN Number | 26-3058238 |
| Address: | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119, US |
| Mail Address: | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119, US |
| Place of Formation: | DELAWARE |
| Name | Role | Address |
|---|---|---|
| ADAMS ADRIAN | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| PARKER STEWART | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| SHAH MAHENDRA | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| Allison David | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| Leaman John | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| Name | Role | Address |
|---|---|---|
| Leman, MD John | Chief Financial Officer | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| Event Type | Filed Date | Value | Description |
|---|---|---|---|
| REVOKED FOR ANNUAL REPORT | 2024-09-27 | No data | No data |
| NAME CHANGE AMENDMENT | 2022-08-03 | IMPEL PHARMACEUTICALS INC. | No data |
| Name | Date |
|---|---|
| Reg. Agent Resignation | 2024-07-03 |
| ANNUAL REPORT | 2023-02-28 |
| Name Change | 2022-09-13 |
| ANNUAL REPORT | 2022-04-22 |
| Foreign Profit | 2021-07-29 |
Date of last update: 01 Feb 2025
Sources: Florida Department of State
